These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7346489)

  • 1. Non-steroidal anti-inflammatory agents in the horse.
    Snow D
    In Pract; 1981 Sep; 3(5):24-5, 27-8, 30-1. PubMed ID: 7346489
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of various non-steroidal anti-inflammatory agents in horses and cattle].
    Hesselholt M; Friis C
    Nord Vet Med; 1985; 37(6):329-37. PubMed ID: 3879699
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of drugs used in the treatment of osteoarthrosis on stromelysin (proteoglycanase) of equine synovial cell origin.
    May SA; Hooke RE; Lees P
    Equine Vet J Suppl; 1988 Sep; (6):28-32. PubMed ID: 9079060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses.
    Keegan KG; Messer NT; Reed SK; Wilson DA; Kramer J
    Am J Vet Res; 2008 Feb; 69(2):167-73. PubMed ID: 18241011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flunixin meglumine: quantitative determination in and effects on composition of equine inflammatory exudate.
    Higgins AJ; Lees P; Taylor JB; Ewins CP
    Br Vet J; 1986; 142(2):163-9. PubMed ID: 3708310
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
    Foreman JH; Grubb TL; Inoue OJ; Banner SE; Ball KT
    Equine Vet J Suppl; 2010 Nov; (38):601-5. PubMed ID: 21059067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.
    Semrad SD; Sams RA; Harris ON; Ashcraft SM
    Am J Vet Res; 1993 Nov; 54(11):1901-5. PubMed ID: 8291770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Association of Equine Practitioners (AAEP).
    White NA
    J Am Vet Med Assoc; 1995 Oct; 207(7):884-5; discussion 890-4. PubMed ID: 7559014
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
    Erkert RS; MacAllister CG; Payton ME; Clarke CR
    Am J Vet Res; 2005 Feb; 66(2):284-8. PubMed ID: 15757129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
    Reed SK; Messer NT; Tessman RK; Keegan KG
    Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
    Foreman JH; Ruemmler R
    Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthesia case of the month. EPAM.
    Clark-Price SC; Gutierrez-Nibeyro SD; Santos MP
    J Am Vet Med Assoc; 2012 Jan; 240(1):40-4. PubMed ID: 22171753
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin.
    Lees P; Ewins CP; Taylor JB; Sedgwick AD
    Br Vet J; 1987; 143(5):462-76. PubMed ID: 3119142
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drugs: a review. New applications in hypersensitivity reactions of cattle and horses.
    Chand N; Eyre P
    Can J Comp Med; 1977 Jul; 41(3):233-40. PubMed ID: 332290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of endotoxin-induced disruption of equine bowel motility by flunixin and phenylbutazone.
    King JN; Gerring EL
    Equine Vet J Suppl; 1989 Jun; (7):38-42. PubMed ID: 9118104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postpartum hemoperitoneum and septic peritonitis in a Thoroughbred mare.
    Mogg TD; Hart J; Wearn J
    Vet Clin North Am Equine Pract; 2006 Apr; 22(1):61-71. PubMed ID: 16627105
    [No Abstract]   [Full Text] [Related]  

  • 18. Infectious temporomandibular joint disease in the horse: computed tomographic diagnosis and treatment of two cases.
    Warmerdam EP; Klein WR; van Herpen BP
    Vet Rec; 1997 Aug; 141(7):172-4. PubMed ID: 9290196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein binding and in vitro serum thromboxane B2 inhibition by flunixin meglumine and meclofenamic acid in dog, goat and horse blood.
    Galbraith EA; McKellar QA
    Res Vet Sci; 1996 Jul; 61(1):78-81. PubMed ID: 8819199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flunixin and its use in horses].
    Jaussaud P
    Ann Rech Vet; 1986; 17(4):353-62. PubMed ID: 3493724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.